Treatment schedule after cancer cell implantation to address the role of TNC in PAX resistance in a xenograft mouse model for breast cancer metastasis to lungs. Mice were implanted with MDA231-LM2 cells expressing either control shRNA (control) or a TNC shRNA (shTNC), treated with paclitaxel or vehicle. 